Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Trace Metal Concentrations Influence Glucose Regulation in Pregnancy

By LabMedica International staff writers
Posted on 12 Jun 2019
Gestational diabetes is a condition in which a woman without diabetes develops high blood sugar levels during pregnancy. More...
Gestational diabetes generally results in few symptoms; however, it does increase the risk of preeclampsia, depression, and requiring a Caesarean section.

Pregnant women with higher plasma concentrations of copper measured during the first trimester were more likely to have elevated glucose levels in the second trimester, increasing the risk for gestational diabetes (GDM), whereas higher concentrations of the trace metal molybdenum were associated with reduced glucose levels.

Scientists from the Harvard T.H. Chan School of Public Health (Boston, MA, USA) and their colleagues analyzed data from 1,857 healthy, normal-weight women from 12 clinical sites in the USA between July 2009 and January 2013. The team measured concentrations of zinc, selenium, copper and molybdenum in blood plasma samples collected during the first trimester of pregnancy (median, 12 weeks’ gestation). Primary outcome was blood glucose levels during the second trimester after a 1-hour 50 g gestational load test (median, 27 weeks’ gestation).

Among 264 women with an abnormal gestational load test, 58 women were diagnosed with gestational diabetes after an oral glucose tolerance test (OGTT). An additional 76 women with a normal gestational load test also underwent an OGTT, with nine women diagnosed with gestational diabetes. The team found that levels of plasma zinc (median, 806 µg/L) and plasma selenium (median, 123 µg/L) were comparable to measurements among non-pregnant women measured in the National Health and Nutrition Examination Survey (NHANES), whereas levels of copper (median, 1,874 µg/L) were higher versus NHANES-measured levels.

The investigators found that higher concentrations of copper measured during the first trimester were associated with higher glucose levels measured during the second trimester, with each 50% increase in copper concentrations related to a 4.9 mg/dL higher glucose level measured via the gestational load test. In contrast, a 50% increase in molybdenum concentrations was associated with a 1.2 mg/dL lower mean glucose level measured via gestational load test. For every 50% increase in copper concentration, women were 1.53 times more likely to have an abnormal gestational load test and for every 50% increase in molybdenum, women were 14% less likely to have an abnormal gestational load test.

The authors concluded that higher copper and lower molybdenum concentrations could increase the risk of glucose dysregulation during pregnancy, with women at higher risk of GDM potentially affected to a greater extent. Further work is needed to understand the mechanisms involved with early pregnancy essential metal(loid)s in order to inform clinical diagnosis and prevention for glucose intolerance during pregnancy. The study was published on May 16, 2019, in The Journal of Clinical Endocrinology & Metabolism.

Related Links:
Harvard T.H. Chan School of Public Health


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Manual Pipetting Aid
Pipette Controllers macro
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.